Great comments by Daniel E Spratt on PSMA therapy
1. Should be treated as radiation treatment and not drug
2. Activity (not dose) should be adapted to tumor burden to ensure proper efficacy
3. Impact of fractionation needs to be studied
#APCCC24

Proud to represent & walk with our amazing University Hospitals #GIOncology team, sponsoring Cleveland’s #PanCANPurpleStride today! PanCAN is a fantastic organization doing so much to better the world for patients & families facing pancreatic cancer. What a great morning RadOncUH 💜

Amazing turnout to Cleveland’s #PurpleStride2024 ! Proud to have our very own Lauren Henke, MD, MSCI kicking off the event with PanCAN and Natalie Herbick from fox8news 💜
We are honored to share these moments, steps, and mission with our patients 💜

We're thrilled to extend a warm welcome to all the amazing students joining our CanSUR program this summer!

Grateful for our department RadOncUH under the leadership of Daniel E Spratt to receive a shoutout at the 2024 University Hospitals State of Research Address by Daniel I. Simon, M.D. highlighting the success of @Lauren_Henke & the The McClelland Lab!
#RadOnc #NAVAH #AdaptiveRT #bcsm #pcsm #KillCancer

Where’s my #RadOnc & #MedPhys swifties at?! Can’t wait!!

Kevin Moore Elizabeth Covington Kristy Brock Dennis N Stanley
Todd Atwood Leigh Conroy Afua Yorke PhD 🇬🇭✈🇺🇸 Dr. Rebecca M. Howell, PhD
MedPhysLindsay Jon J Kruse Jona Hattangadi-Gluth, MD Lauren Henke, MD, MSCI

Spending some time reading about QOL measures in oncology trials, & not feeling too reassured. Some issues I’ve seen:

-Little consistency on what is considered clinically meaningful

-Range of survey instruments used

-Lots of drop off, particularly at later time points. If a…

Getting existential advice from a Midwest sewer system was not in my plan but, hey, here we are. Be open to life learnings where you find them.

I am so proud of all the accomplishments my colleagues at UH Radiology Cleveland have had under the leadership of Donna Plecha in advancing radiology research and innovation, and contributing to the success of UH Research & Education Institute CWRU School of Medicine.
At University Hospitals State of Research by Daniel I. Simon, M.D..

⁦John Suh⁩ and I excited to kick off the Best of Radiation Oncology in Cleveland. Great line up and collaboration between ⁦RadOncUH⁩ ⁦Cleveland Clinic⁩

2 years ago today, I had the honor of watching my HAI partner in crime implant our program's first pump. The journey has not been easy, but I am so grateful to be able to offer this therapy to our patients & am grateful to have Lee M. Ocuin MD, FACS as my partner. Happy pumpiversary!

So excited to offer a URiM-based scholarship through our institution to rotate here at UH/CWRU! Apply thru VSLO and the application thru the QR code! My DMs are open, please reach out if you have any questions, concerns, or need any help!!!

📢: Attention incoming MS4s! We have a scholarship available for URiM students wishing to rotate with us RadOncUH Case Comp Cancer Ctr! $2500 scholarship to offset travel costs, and get to meet our stellar team focused on  #DEIinRO #sponsorship #education ! Apply today!

Michael Fischbach SU2Cscience @SU2C John Kincade Scholar-in-Training Award recipient and MSK Department of Medicine Stefanie Gerstberger, MD PhD and former Scholar-In-Training awardee and current CWRU School of Medicine Oncologist Melissa Lumish MD will be sharing their discoveries on the #microbiome of #CRC

Grateful for ongoing mentorship from Karuna Ganesh and the opportunity to present early findings from our longitudinal study of #microbiome correlates of early age at onset and tumor sidedness in #CRC Memorial Sloan Kettering Cancer Center University Hospitals Case Comp Cancer Ctr